Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine

NCT04153409 is registered in ClinicalTrials.gov with Lateral Pharma Pty Ltd as lead sponsor.

NCT NCT04153409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04153409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
Lead sponsor
Lateral Pharma Pty Ltd
Phase
Phase 2
Overall status
Completed
Start date
September 24, 2019
Completion date
April 10, 2020
Enrollment
21 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine